Lupus erythematosus manifestations exacerbated by etanercept therapy in a patient with mixed connective tissue disease.

Richez, C; Blanco, P; Dumoulin, C; Schaeverbeke, T

Richez, C; Blanco, P; Dumoulin, C; Schaeverbeke, T.

Clin Exp Rheumatol ; 23(2): 273, 2005.

Article in En | MEDLINE | ID: mdl-15895904

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Immunoglobulin G/adverse effects; Lupus Erythematosus, Systemic/pathology; Mixed Connective Tissue Disease/pathology; Recombinant Fusion Proteins/adverse effects; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adult; Arthritis/etiology; Arthritis/pathology; Etanercept; Female; Humans; Lupus Erythematosus, Systemic/chemically induced; Lupus Erythematosus, Systemic/etiology; Mixed Connective Tissue Disease/complications; Mixed Connective Tissue Disease/drug therapy; Receptors, Tumor Necrosis Factor; Treatment Outcome; Withholding Treatment

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin G / Anti-Inflammatory Agents, Non-Steroidal / Tumor Necrosis Factor-alpha / Lupus Erythematosus, Systemic / Mixed Connective Tissue Disease Type of study: Etiology_studies Limits: Adult / Female / Humans Language: En Journal: Clin Exp Rheumatol Year: 2005 Document type: Article Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links